To study the safety and efficacy of Simvastatin in the acute phase of ischemic stroke.
- Simvastatin Drug
Intervention Desc: HMG-CoA reductase inhibitor; lowers cholesterol
Pilot, randomized, double-blind, multi-center clinical trial.
Patients were randomized to receive either Simvastatin (n=28) or placebo (n=28) 40mg until day 7 and 20mg until day 90.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Efficacy and neurological outcome at day 1, 3, 5, 7 and 90.|